You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美个人护理巨擘强生65亿美元并购Momenta医药
阿思达克 08-20 10:20
美国个人护理与药业巨擘强生(Johnson & Johnson)(JNJ.US)宣布,同意以65亿美元收购药厂Momenta Pharmaceuticals(MNTA.US),以扩大其於自体免疫性疾病的药物组合。Momenta股价昨(19日)急升69.2%。

Momenta研发药物nipocalimab在应对抗体溶血反应问题上处後期测试,在重症肌无力治疗则处中期测试。强生表示,该药将取得治疗多种自体免疫性疾病的许可。

法国赛诺菲(Sanofi)早前以37亿美元收购Principia Biopharma(PRNB.US),以增强自体免疫性疾病的药物组合。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account